Stay updated on PANGEA-IMBBP Clinical Trial
Sign up to get notified when there's something new on the PANGEA-IMBBP Clinical Trial page.

Latest updates to the PANGEA-IMBBP Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, and confirmed the NIH Clinical Center is open with sources. - Version updated from v3.1.0 to v3.2.0.SummaryDifference4%
- Check21 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2, indicating a minor patch. The Back to Top element was removed; no substantive changes to core content, pricing, or availability.SummaryDifference0.2%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check50 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new drug information for several monoclonal antibodies and proteins. Notably, bemarituzumab has been reintroduced, while several previous drug categories and terms have been removed.SummaryDifference3%
- Check65 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to PANGEA-IMBBP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PANGEA-IMBBP Clinical Trial page.